Candriam SCA’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.01M | Sell |
76,727
-3,203
| -4% | -$334K | 0.05% | 285 |
|
|
2025
Q1 | $9.32M | Buy |
+79,930
| New | +$9.32M | 0.06% | 246 |
|
|
2024
Q2 | – | Sell |
-75,084
| Closed | -$5.99M | – | 693 |
|
|
2024
Q1 | $5.99M | Sell |
75,084
-10,000
| -12% | -$798K | 0.04% | 313 |
|
|
2023
Q4 | $6.77M | Buy |
85,084
+35,000
| +70% | +$2.79M | 0.05% | 303 |
|
|
2023
Q3 | $3.5M | Hold |
50,084
| – | – | 0.02% | 355 |
|
|
2023
Q2 | $3.6M | Sell |
50,084
-45,000
| -47% | -$3.23M | 0.03% | 390 |
|
|
2023
Q1 | $5.4M | Sell |
95,084
-76,390
| -45% | -$4.34M | 0.04% | 346 |
|
|
2022
Q4 | $13.2M | Buy |
171,474
+61,094
| +55% | +$4.71M | 0.09% | 220 |
|
|
2022
Q3 | $4.93M | Sell |
110,380
-4,704
| -4% | -$210K | 0.03% | 381 |
|
|
2022
Q2 | $4.41M | Hold |
115,084
| – | – | 0.04% | 342 |
|
|
2022
Q1 | $4.76M | Buy |
115,084
+20,727
| +22% | +$858K | 0.03% | 358 |
|
|
2021
Q4 | $3.57M | Sell |
94,357
-59,245
| -39% | -$2.24M | 0.02% | 430 |
|
|
2021
Q3 | $5.06M | Buy |
153,602
+35,000
| +30% | +$1.15M | 0.03% | 398 |
|
|
2021
Q2 | $8M | Buy |
118,602
+2,800
| +2% | +$189K | 0.05% | 318 |
|
|
2021
Q1 | $9.06M | Hold |
115,802
| – | – | 0.08% | 268 |
|
|
2020
Q4 | $9.44M | Buy |
115,802
+15,347
| +15% | +$1.25M | 0.07% | 274 |
|
|
2020
Q3 | $7.16M | Buy |
+100,455
| New | +$7.16M | 0.07% | 286 |
|